Aflac Reports Mixed Q4 Results, Boosts Shareholder Returns

AFLAC ( (AFL) ) has issued an announcement.

On February 4, 2026, Aflac reported that fourth-quarter 2025 total revenues fell to $4.9 billion from $5.4 billion a year earlier, with net earnings declining to $1.4 billion, or $2.64 per diluted share, from $1.9 billion, or $3.42 per share, largely reflecting lower net investment gains. Adjusted earnings dipped 5.4% to $818 million, but adjusted earnings per share inched up to $1.57, aided by share repurchases and despite softer variable investment income and a slightly weaker yen that did not affect per-share results. For full-year 2025, revenues decreased 9.3% to $17.2 billion and net earnings dropped to $3.6 billion from $5.4 billion, while adjusted earnings were roughly flat at $4.0 billion and adjusted EPS rose to $7.49, supported by capital returns. In Japan, premiums and investment income declined modestly for the quarter and year in both yen and dollar terms, but profitability remained strong and new annualized premium sales surged about 16% for 2025, driven by strong demand for the Miraito cancer product and supported by the newer Tsumitasu and Anshin Palette offerings. In the U.S., quarterly net earned premiums grew 4.0% and full-year premiums rose 2.9%, though pretax adjusted earnings margin compressed on higher benefits and expenses; new sales increased 3.0% for the year, underscoring Aflac’s focus on more profitable growth and strong policy persistency. The board reaffirmed its previously announced 5.2% first-quarter dividend increase to $0.61 per share and Aflac returned additional capital to shareholders by repurchasing $800 million of stock in the fourth quarter, leaving substantial authorization remaining and highlighting management’s confidence in cash flow generation and capital strength.

The most recent analyst rating on (AFL) stock is a Hold with a $100.00 price target. To see the full list of analyst forecasts on AFLAC stock, see the AFL Stock Forecast page.

Spark’s Take on AFL Stock

According to Spark, TipRanks’ AI Analyst, AFL is a Neutral.

AFLAC’s overall stock score reflects strong financial performance and positive earnings call highlights, tempered by technical analysis indicators suggesting bearish sentiment. Valuation is reasonable, and corporate events provide additional positive momentum.

To see Spark’s full report on AFL stock, click here.

More about AFLAC

Aflac Incorporated (NYSE: AFL) is a leading provider of supplemental health and life insurance, with major operations in Japan and the United States. The company focuses on third-sector products such as cancer and medical insurance in Japan and voluntary/worksite benefits in the U.S., targeting both individual and group customers and emphasizing long-term, integrated financial protection solutions.

Average Trading Volume: 2,387,282

Technical Sentiment Signal: Strong Buy

Current Market Cap: $58.67B

For detailed information about AFL stock, go to TipRanks’ Stock Analysis page.